Burkhard Brandt

11.1k total citations · 2 hit papers
165 papers, 8.6k citations indexed

About

Burkhard Brandt is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Burkhard Brandt has authored 165 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Oncology, 64 papers in Molecular Biology and 49 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Burkhard Brandt's work include HER2/EGFR in Cancer Research (39 papers), Cancer Cells and Metastasis (30 papers) and Monoclonal and Polyclonal Antibodies Research (23 papers). Burkhard Brandt is often cited by papers focused on HER2/EGFR in Cancer Research (39 papers), Cancer Cells and Metastasis (30 papers) and Monoclonal and Polyclonal Antibodies Research (23 papers). Burkhard Brandt collaborates with scholars based in Germany, Netherlands and United States. Burkhard Brandt's co-authors include Horst Buerger, Klaus Pantel, Ruud H. Brakenhoff, Kurt S. Zänker, Nicola Tidow, Michael Thomas, Frank Gebhardt, Wolfgang E. Berdel, Wenbing Wang and Ralf Metzger and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Nature reviews. Cancer.

In The Last Decade

Burkhard Brandt

161 papers receiving 8.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer

2003 1.8k citations Nicola Tidow, Burkhard Brandt et al. profile →
Detection, clinical relevance and specific biological properties of disseminating tumour cells

2008 930 citations Klaus Pantel, Burkhard Brandt et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Burkhard Brandt Germany	48	4.2k	3.5k	3.3k	1.8k	689	165	8.6k
Jahn M. Nesland Norway	53	3.5k 0.8×	3.7k 1.0×	2.3k 0.7×	2.2k 1.2×	798 1.2×	194	9.1k
Ian C. MacDonald Canada	37	3.4k 0.8×	4.2k 1.2×	2.3k 0.7×	1.2k 0.6×	1.2k 1.8×	70	8.7k
Glen J. Weiss United States	44	4.2k 1.0×	3.1k 0.9×	1.9k 0.6×	1.9k 1.0×	349 0.5×	209	7.9k
Don X. Nguyen United States	26	4.0k 0.9×	4.0k 1.1×	2.4k 0.7×	1.6k 0.9×	571 0.8×	55	8.1k
Gunhild M. Mælandsmo Norway	49	5.1k 1.2×	3.3k 0.9×	2.4k 0.7×	1.3k 0.7×	725 1.1×	219	8.7k
Hans‐Peter Sinn Germany	47	2.9k 0.7×	3.4k 1.0×	3.3k 1.0×	955 0.5×	613 0.9×	260	8.3k
Neil A. Bhowmick United States	51	6.8k 1.6×	4.3k 1.2×	2.6k 0.8×	2.0k 1.1×	512 0.7×	144	11.4k
William P. Schiemann United States	59	6.8k 1.6×	3.5k 1.0×	2.4k 0.7×	1.3k 0.7×	481 0.7×	132	11.1k
Kristian Pietras Sweden	46	6.4k 1.5×	4.3k 1.2×	2.6k 0.8×	1.8k 1.0×	1.5k 2.2×	99	12.2k
A. C. Groom Canada	37	3.3k 0.8×	4.1k 1.2×	2.2k 0.7×	1.2k 0.7×	1.1k 1.7×	105	8.6k

Countries citing papers authored by Burkhard Brandt

Since Specialization

Citations

This map shows the geographic impact of Burkhard Brandt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Burkhard Brandt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Burkhard Brandt more than expected).

Fields of papers citing papers by Burkhard Brandt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Burkhard Brandt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Burkhard Brandt. The network helps show where Burkhard Brandt may publish in the future.

Co-authorship network of co-authors of Burkhard Brandt

This figure shows the co-authorship network connecting the top 25 collaborators of Burkhard Brandt. A scholar is included among the top collaborators of Burkhard Brandt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Burkhard Brandt. Burkhard Brandt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eisenhauer, Anton, et al.. (2024). Calcium isotope composition in serum and urine for the assessment of bone mineral balance (BMB) – The Osteolabs post-market follow-up study. Bone. 188. 117210–117210. 3 indexed citations

Nastały, Paulina, Marta Popęda, Emanuele Martini, et al.. (2021). Low Tumor-to-Stroma Ratio Reflects Protective Role of Stroma against Prostate Cancer Progression. Journal of Personalized Medicine. 11(11). 1088–1088. 5 indexed citations

Nastały, Paulina, Aneta Bałabas, Michalina Dąbrowska, et al.. (2018). Somatic aberrations of BRCA1 gene are associated with ALDH1, EGFR, and tumor progression in prostate cancer. International Journal of Cancer. 144(3). 607–614. 11 indexed citations

Grabinski, Nicole, Karin Milde‐Langosch, Volkmar Müller, et al.. (2014). AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2+ breast tumor cells from Balb-neuT mice. Cellular Signalling. 26(5). 1021–1029. 38 indexed citations

Bartkowiak, Kai, Antje Andreas, Klaus Pantel, et al.. (2012). The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC ‐γ 1 signalling in breast cancer cell migration and dissemination. The Journal of Pathology. 227(2). 234–244. 76 indexed citations

Grabinski, Nicole, Kai Bartkowiak, Katharina Grupp, et al.. (2011). Distinct functional roles of Akt isoforms for proliferation, survival, migration and EGF-mediated signalling in lung cancer derived disseminated tumor cells. Cellular Signalling. 23(12). 1952–1960. 69 indexed citations

Hungermann, D., H Schmidt, Rachael Natrajan, et al.. (2011). Influence of whole arm loss of chromosome 16q on gene expression patterns in oestrogen receptor‐positive, invasive breast cancer. The Journal of Pathology. 224(4). 517–528. 27 indexed citations

Bednarz‐Knoll, Natalia, Elke Eltze, Axel Semjonow, et al.. (2010). BRCA1 Loss Preexisting in Small Subpopulations of Prostate Cancer Is Associated with Advanced Disease and Metastatic Spread to Lymph Nodes and Peripheral Blood. Clinical Cancer Research. 16(13). 3340–3348. 53 indexed citations

Helms, Mike W., Dirk Kemming, Christopher H. Contag, et al.. (2009). TOB1 Is Regulated by EGF-Dependent HER2 and EGFR Signaling, Is Highly Phosphorylated, and Indicates Poor Prognosis in Node-Negative Breast Cancer. Cancer Research. 69(12). 5049–5056. 33 indexed citations

10.

Liedtke, Cornelia, Jens Packeisen, H Schmidt, et al.. (2006). In vitro chemosensitivity testing in invasive breast cancer: Increased sensitivity of the basal subtype is not independent of the tumor proliferation rate. Clinical Cancer Research. 12. 1 indexed citations

11.

Brandt, Burkhard, et al.. (2005). Selective expression of a splice variant of decay-accelerating factor in c-erbB-2-positive mammary carcinoma cells showing increased transendothelial invasiveness. Biochemical and Biophysical Research Communications. 329(1). 318–323. 4 indexed citations

12.

Kersting, Christian, Nicola Tidow, H Schmidt, et al.. (2004). Gene dosage PCR and fluorescence in situ hybridization reveal low frequency of egfr amplifications despite protein overexpression in invasive breast carcinoma. Laboratory Investigation. 84(5). 582–587. 65 indexed citations

13.

Boecker, Werner, R. Moll, P. Dervan, et al.. (2001). A common progenitor (adult stem) cell gives rise to both the glandular and myoepithelial cell lineages. a new cell biological concept as the basis of breast pathology. Breast Cancer Research and Treatment. 69(3). 1 indexed citations

14.

Azémar, Marc, Mathias Schmidt, Burkhard Brandt, et al.. (2000). Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit thein vitro growth of human head and neck cancer cells and cause rapid tumor regressionin vivo. International Journal of Cancer. 86(2). 269–275. 86 indexed citations

15.

Dittmar, Thomas, et al.. (2000). Accelerated Assessing of Antisense RNA Efficacy Using a Chimeric Enhanced Green Fluorescent Protein-Antisense RNA-Producing Vector. Antisense and Nucleic Acid Drug Development. 10(5). 401–408. 8 indexed citations

16.

Werkmeister, R., et al.. (1999). Chemosensitivity testing of oral cancer cells treated with a p185^neu‐specific agent. European Journal Of Oral Sciences. 107(5). 338–343. 2 indexed citations

17.

Gebhardt, Frank, Kurt S. Zänker, & Burkhard Brandt. (1998). Differential Expression of Alternatively Spliced c-erbB-2 mRNA in Primary Tumors, Lymph Node Metastases, and Bone Marrow Micrometastases from Breast Cancer Patients. Biochemical and Biophysical Research Communications. 247(2). 319–323. 20 indexed citations

18.

Dittmar, Thomas, et al.. (1998). Selection of Potentially Metastatic Subpopulations Expressing c-erbB-2 from Breast Cancer Tissue by Use of an Extravasation Model. American Journal Of Pathology. 153(6). 1797–1806. 51 indexed citations

19.

Brandt, Burkhard, et al.. (1998). Isolation of blood-borne epithelium-derived c-erbB-2 oncoprotein-positive clustered cells from the peripheral blood of breast cancer patients. International Journal of Cancer. 76(6). 824–828. 69 indexed citations

20.

Beckmann, Alf, Frank Gebhardt, & Burkhard Brandt. (1998). Direct quantification of polymerase chain reaction fragments using field-amplified sample injection in capillary zone electrophoresis for gene dosage estimation. Journal of Chromatography B. 710. 75–8012. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact